Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Lin28 Blocking Peptide (AC1250)
Cat.#: ACPP-1250
Specifications
Despition Lin28 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1110 Recombinant Human ROR1 Protein (6×His Tag) (AC1110) 50 µg inquiry ACPP-1363 Presenilin 1 Blocking Peptide (AC1363) 250 µg inquiry ACPP-1597 Human CRYGS Protein (AC1597) 5 µg inquiry ACPP-1332 GAD65 Blocking Peptide (AC1332) 250 µg inquiry ACPP-1750 Human LCN1 Protein (AC1750) 5 µg inquiry ACPP-1614 Human MPPED2 Protein (AC1614) 2 µg inquiry ACPP-1641 Adenylate cyclase 1 Blocking Peptide (AC1641) 250 µg inquiry ACPP-1326 Galectin 3 Blocking Peptide (AC1326) 250 µg inquiry ACPP-1474 Human RGS21 Protein (AC1474) 5 µg inquiry ACPP-1120 Human NRG1 Protein (AC1120) 10 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket